Results 161 to 170 of about 73,750 (253)

Transmission Ratio Distortion in Genetic Prion Diseases: Clarifying Methodological Considerations. [PDF]

Eur J Neurol
Kortazar-Zubizarreta I, Manero-Azua A, Eraña H, Castilla J, Perez de Nanclares G.   +4 more
europepmc   +1 more source

A Theoretical Framework on the Biology of Prion Diseases. [PDF]

Acta Inform Med, 2023
Ramosaço E, Bajrami N, Vyshka G.
europepmc   +1 more source

The Risk of Transmission of Genetic Prion Diseases is Greater Than 50. [PDF]

Eur J Neurol
Kortazar-Zubizarreta I, Manero-Azua A, Eraña H, Aguire U, Castilla J, Perez de Nanclares G.   +5 more
europepmc   +1 more source

Ferroptosis-related mechanisms in prion diseases provide insights into neurodegeneration and reveal therapeutic implications. [PDF]

Redox Biol
Zayed M, Tayara H, Jeong BH.
europepmc   +1 more source

Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases. [PDF]

Acta Neuropathol Commun
Wang Y, Mohammadi B, Hartmann C, Hartmann K, Thies E, Matamoros-Angles A, Fang C, Harris DA, Tatzelt J, Altmeppen HC, Sepulveda-Falla D, Strittmatter SM, Glatzel M, Krasemann S.   +13 more
europepmc   +1 more source

Geographic Diversity in the Incidence of Human Prion Diseases - China, 2006-2019. [PDF]

China CDC Wkly, 2023
Shi Q, Xiao K, Gao L, Wu Y, Zhou W, Liang D, Chen C, Dong X.   +7 more
europepmc   +1 more source

Etiology matters: genetic and acquired prion diseases engage different mechanisms at a presymptomatic stage. [PDF]

Neural Regen Res, 2023
Jackson WS.
europepmc   +1 more source

Early Diagnostic Measures to Confirm the Diagnosis of Human Prion Diseases. [PDF]

Cureus, 2023
Desai N, Purzycki T.
europepmc   +1 more source

Redox mechanisms and their pathological role in prion diseases: The road to ruin. [PDF]

PLoS Pathog, 2023
Spiers JG, Chen HC, Steinert JR.
europepmc   +1 more source

The Evolution of Experimental Rodent Models for Prion Diseases. [PDF]

J Neurochem
DeFranco JP, Telling GC.
europepmc   +1 more source